Matthew O. Hebb

Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting

Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)

Expression of the Huntington's disease gene is regulated in astrocytes in the arcuate nucleus of the hypothalamus of postpartum rats

End-capped antisense oligodeoxynucleotides effectively inhibit gene expression in vivo and offer a low-toxicity alternative to fully modified phosphorothioate oligodeoxynucleotides